Lead Product(s) : Sonidegib Phosphate
Therapeutic Area : Oncology
Study Phase : Phase IV
Sponsor : Sun Pharmaceutical Industries Limited | Zhejiang Hangyu Pharmaceutical Co., Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in China
Details : Sonidegib Phosphate is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Carcinoma, Basal Cell.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 18, 2025
Lead Product(s) : Sonidegib Phosphate
Therapeutic Area : Oncology
Highest Development Status : Phase IV
Sponsor : Sun Pharmaceutical Industries Limited | Zhejiang Hangyu Pharmaceutical Co., Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Sonidegib Phosphate
Therapeutic Area : Oncology
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : ODOMZO (sonidegib) works by inhibiting a molecular pathway, known as the hedgehog signaling pathway, which is indicated for the treatment of adult patients with locally advanced basal cell carcinoma.
Product Name : Odomzo
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 12, 2020
Lead Product(s) : Sonidegib Phosphate
Therapeutic Area : Oncology
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
